Institutional members access full text with Ovid®

Mammography utilization in women aged 4049 years: the French EDIFICE survey

Pivot, Xaviera,b; Eisinger, Françoisc,d; Blay, Jean-Yvese,f; Coscas, Yvang; Calazel-Benque, Anneh; Viguier, Jérômei; Roussel, Clairej; Morère, Jean-Françoisk,l

European Journal of Cancer Prevention: January 2011 - Volume 20 - Issue - p S16–S19
doi: 10.1097/01.cej.0000391565.41383.ba
Supplement Articles

In France, mammography screening is offered to women aged between 50 and 74 years. EDIFICE, the iterative nationwide survey, collected data on a national level aboutconsumers utilization of available cancer screening procedures. This analysis compared data from a subset of241 women aged between 40 and 50 years with that of488 women aged between 50 and 74 years. Multivariate analysis showed the following significant factors to be linked with screening attendance for women younger than50 years: age, with a threshold value at 44 years; awareness of the recommended screening period (2years); consultation within the last 12 months with ageneral practitioner or a gynaecologist; and long standinglocal programme for colon cancer screening. Notwithstanding the debate on risk/benefit of breast cancer screening for women in their 40s, we observed more differences with regard to attendance between women aged 40–45 years versus that of 46–74 years than between women aged 40–49 years versus that of 50–74 years. The issue that is unanswered as yet is, do women make a kind of heuristic for starting breast cancer screening, leading them to a threshold choice of 45 years or alternatively to a collective answer of standard age minus 5 years!

aUniversity Hospital Jean Minjoz

bINSERM U645, Besançon

cPaoli-Calmettes Institute

dINSERM UMR 912, Marseille

eLéon Bérard Cancer Center

fINSERM U590, Centre L Bérard & Conticanet, Lyon

gPorte de St Cloud Clinic, Boulogne-Billancourt

hClinique du Parc, Toulouse

iCancer Screening Department, University Hospital Centre of Tours

jRoche S.A., Neuilly-sur-Seine

kAvicenne University Hospital, Bobigny

lUniversity Paris XII, Paris, France

Correspondence to Xavier Pivot, Department of Medical Oncology, University Hospital Jean Minjoz, 25030 Besançon Cedex, France Tel: +33 3 81 66 86 93; fax: +33 3 81 66 88 08; e-mail: xavier.pivot@univ-fcomte.fr

© 2011 Lippincott Williams & Wilkins, Inc.